» Articles » PMID: 24385903

Systematic MicroRNA Analysis Identifies ATP6V0C As an Essential Host Factor for Human Cytomegalovirus Replication

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2014 Jan 4
PMID 24385903
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in microRNA target identification have greatly increased the number of putative targets of viral microRNAs. However, it is still unclear whether all targets identified are biologically relevant. Here, we use a combined approach of RISC immunoprecipitation and focused siRNA screening to identify targets of HCMV encoded human cytomegalovirus that play an important role in the biology of the virus. Using both a laboratory and clinical strain of human cytomegalovirus, we identify over 200 putative targets of human cytomegalovirus microRNAs following infection of fibroblast cells. By comparing RISC-IP profiles of miRNA knockout viruses, we have resolved specific interactions between human cytomegalovirus miRNAs and the top candidate target transcripts and validated regulation by western blot analysis and luciferase assay. Crucially we demonstrate that miRNA target genes play important roles in the biology of human cytomegalovirus as siRNA knockdown results in marked effects on virus replication. The most striking phenotype followed knockdown of the top target ATP6V0C, which is required for endosomal acidification. siRNA knockdown of ATP6V0C resulted in almost complete loss of infectious virus production, suggesting that an HCMV microRNA targets a crucial cellular factor required for virus replication. This study greatly increases the number of identified targets of human cytomegalovirus microRNAs and demonstrates the effective use of combined miRNA target identification and focused siRNA screening for identifying novel host virus interactions.

Citing Articles

HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions.

Blanco R, Munoz J Viruses. 2024; 16(11).

PMID: 39599814 PMC: 11599080. DOI: 10.3390/v16111699.


Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.

Sabbaghian M, Gheitasi H, Fadaee M, Javadi Henafard H, Tavakoli A, Shekarchi A Arch Virol. 2024; 169(8):157.

PMID: 38969819 DOI: 10.1007/s00705-024-06080-w.


Current Knowledge on the Interaction of Human Cytomegalovirus Infection, Encoded miRNAs, and Acute Aortic Syndrome.

Nappi F, Alzamil A, Avtaar Singh S, Spadaccio C, Bonnet N Viruses. 2023; 15(10).

PMID: 37896804 PMC: 10611417. DOI: 10.3390/v15102027.


Deletion of the non-adjacent genes and impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation.

Le-Trilling V, Maassen F, Katschinski B, Hengel H, Trilling M Front Immunol. 2023; 14:1170300.

PMID: 37600801 PMC: 10437809. DOI: 10.3389/fimmu.2023.1170300.


Combined nanopore and single-molecule real-time sequencing survey of human betaherpesvirus 5 transcriptome.

Kakuk B, Tombacz D, Balazs Z, Moldovan N, Csabai Z, Torma G Sci Rep. 2021; 11(1):14487.

PMID: 34262076 PMC: 8280142. DOI: 10.1038/s41598-021-93593-y.


References
1.
Dolken L, Malterer G, Erhard F, Kothe S, Friedel C, Suffert G . Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe. 2010; 7(4):324-334. DOI: 10.1016/j.chom.2010.03.008. View

2.
Murphy E, Vanicek J, Robins H, Shenk T, Levine A . Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A. 2008; 105(14):5453-8. PMC: 2291141. DOI: 10.1073/pnas.0711910105. View

3.
Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser F . Identification of microRNAs of the herpesvirus family. Nat Methods. 2005; 2(4):269-76. DOI: 10.1038/nmeth746. View

4.
Rue C, Jarvis M, Knoche A, Meyers H, DeFilippis V, Hansen S . A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol. 2004; 78(22):12529-36. PMC: 525102. DOI: 10.1128/JVI.78.22.12529-12536.2004. View

5.
Tegtmeier G . The use of cytomegalovirus-screened blood in neonates. Transfusion. 1988; 28(3):201-3. DOI: 10.1046/j.1537-2995.1988.28388219141.x. View